Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sol-Gel Technologies (SLGL)
NASDAQ:SLGL
Sol-Gel Technologies (SLGL) Stock Price & Analysis
345 Followers
SLGL Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.63 - $4.05
Previous Close$0.88
Volume130.97K
Average Volume (3M)35.29K
Market Cap
$24.57M
Enterprise Value-$1.76M
Total Cash (Recent Filing)$27.98M
Total Debt (Recent Filing)$1.65M
Price to Earnings (P/E)―
Beta0.63
Next Earnings
Aug 08, 2024EPS Estimate
-$0.2Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.82
Shares Outstanding27,857,620
10 Day Avg. Volume32,503
30 Day Avg. Volume35,292
Standard Deviation0.22
R-Squared0.14
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)0.60
Price to Sales (P/S)14.88
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-0.47
Enterprise Value/Gross Profit-1.13
Enterprise Value/Ebitda0.43
Forecast
1Y Price Target
$6.00Price Target Upside580.27% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Sol-Gel Technologies News
PremiumCompany Announcements
Sol-Gel Technologies Announces Leadership Changes
PremiumCompany Announcements
Sol-Gel Technologies Faces NASDAQ Non-Compliance
PremiumCompany Announcements
Sol-Gel Advances Dermatology Treatments and Secures New Deal
Bulls Say, Bears Say
Bulls Say
Financial PerformanceSol-Gel ended 1Q24 with approximately $33M in cash, cash equivalents, bank deposits, and marketable securities, expected to fund operations into the second half of 2025.
Market ExpansionSol-Gel announced that it has signed an asset purchase agreement with China-based Shenzhen Beimei Pharmaceutical Co. Ltd. for the commercialization of Twyneo in treatment of acne vulgaris across mainland China, Hong Kong, Macau, Taiwan and Israel.
Product CoverageManaged care coverage for TWYNEO increased by 1.5M lives since 4Q23 to 102.2M commercial lives covered.
Bears Say
EarningsSol-Gel reported $0.5M in revenue, falling short of the $0.6M forecast.
Financial PerformanceThe net loss for Sol-Gel was $0.23 per share, considerably larger than the expected $0.16 per share loss.
Stock Price TargetAnalyst is reducing the 12-month price target for Sol-Gel from $9 to $6, reflecting a slower revenue ramp and lower peak sales.
---
Ownership Overview
0.00%
Insiders
0.05% Mutual Funds
26.96% Other Institutional Investors
72.99% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
SLGL FAQ
What was Sol-Gel Technologies’s price range in the past 12 months?
Sol-Gel Technologies lowest stock price was $0.63 and its highest was $4.05 in the past 12 months.
What is Sol-Gel Technologies’s market cap?
Currently, no data Available
When is Sol-Gel Technologies’s upcoming earnings report date?
Sol-Gel Technologies’s upcoming earnings report date is Aug 08, 2024 which is in 21 days.
How were Sol-Gel Technologies’s earnings last quarter?
Sol-Gel Technologies released its earnings results on May 20, 2024. The company reported -$0.23 earnings per share for the quarter, missing the consensus estimate of -$0.155 by -$0.075.
Is Sol-Gel Technologies overvalued?
According to Wall Street analysts Sol-Gel Technologies’s price is currently Undervalued.
Does Sol-Gel Technologies pay dividends?
Sol-Gel Technologies does not currently pay dividends.
What is Sol-Gel Technologies’s EPS estimate?
Sol-Gel Technologies’s EPS estimate is -$0.2.
How many shares outstanding does Sol-Gel Technologies have?
Sol-Gel Technologies has 27,857,620 shares outstanding.
What happened to Sol-Gel Technologies’s price movement after its last earnings report?
Sol-Gel Technologies reported an EPS of -$0.23 in its last earnings report, missing expectations of -$0.155. Following the earnings report the stock price went down -6.667%.
Which hedge fund is a major shareholder of Sol-Gel Technologies?
Currently, no hedge funds are holding shares in SLGL
---
Sol-Gel Technologies Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$6.00 (580.27% Upside)
$6.00 (580.27% Upside)
Crowd Wisdom
Very Negative
Last 7 Days ▼ 6.4%
Last 30 Days ▼ 9.6%
Last 30 Days ▼ 9.6%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-70.84%
12-Months-Change
Fundamentals
Return on Equity
-59.60%
Trailing 12-Months
Asset Growth
-18.62%
Trailing 12-Months
Company Description
Sol-Gel Technologies
Sol-Gel Technologies Ltd. is a clinical-stage dermatology company, which focuses on identifying, developing and commercializing topical dermatological drug products for the treatment of skin diseases. Its products include VERED, TWIN and SIRS-T. The company was founded by David Avnir and Alon Seri-Levy on October 28, 1997 and is headquartered in Ness Ziona, Israel.
---
SLGL Stock 12 Month Forecast
Average Price Target
$6.00
▲(580.27% Upside)
Technical Analysis
Best Analysts Covering SLGL
1 Year
1 Year Success Rate
1/10 ratings generated profit
1 Year Average Return
-52.59%
reiterated a buy rating 2 months ago
Copying Ram Selvaraju's trades and holding each position for 1 Year would result in 10.00% of your transactions generating a profit, with an average return of -52.59% per trade.
---